Menu
  • Join
  • Login
  • Contact
 

Search abstracts


Evaluation of using a fixed-dose combination of glibenclamide and metformin compared to glibenclamide co-administered with metformin in type 2 diabetes outpatients

  • At: 2008 FIP Congress in Basel (Switzerland)
  • Type: Poster
  • By: YEN, Chih-ho (Department of Pharmacy, Taichung Veterans General Hospital, Taichung, Taiwan, Re, Taichung, Taiwan, Republic Of China, China Taiwan)
  • Co-author(s): Chen, Hsiu-Mei (Department of Pharmacy, Taichung Veterans General Hospital, China Taiwan)
    Liu, Ying-Mei (Department of Pharmacy, Taichung Veterans General Hospital, China Taiwan)
    Cheng, Huang-Chi (Department of Pharmacy, Taichung Veterans General Hospital, China Taiwan)
    Chen, Been-Yuan (Department of Pharmacy, Taichung Veterans General Hospital, China Taiwan)
  • Abstract:

    Objectives: The study was conducted to evaluate the efficacy, side effects and economic benefits of using a fixed-dose glibenclamide/metformin tablets compared to glibenclamide co-administered with metformin in type 2 diabetes outpatients.

    Methods: This retrospective study analyzed type 2 diabetes outpatients, who treated with a fixed-dose..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses